The project seeks to design and create training programs for industry associated with the R&D and advanced manufacturing of biologic medicines and more broadly for industry associated with biomedical sciences.
The training program fills a gap in the required knowledge and skills base necessary for advancement of Australian industry. At least 200 individuals will receive training on the R&D and advanced manufacturing of biologic medicines.
- 490 participants receieved training during the project, this is a mixture of in-person training and access to an e-learning platform.
- One additional clinical trial has commenced from the trainees.
Visit the Australian Institute for Bioengineering and Nanotechnology for more details.
LinkedIn: University of Queensland
|Consortium lead||Australian Institute for Bioengineering and Nanotechnology & University of Queensland|
|Consortium members||Abbvie, Australian Red Cross Blood Service (ARCBS), ACYTE Biotech, CSL Ltd, Luina Bio & Patheon Biologics|
|Project duration||May 2018 - February 2020 (Completed)|
|Contact||Professor Stephen Mahler, University of Queensland - email@example.com|